The company has seen no estimate revisions in the past few weeks, although its Zacks Consensus Estimate moved higher over the past 30 days, suggesting that more solid trading could be ahead for Spectranetics. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
The Spectranetics Corporation currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Some better-ranked stocks in the broader health care sector include Valeant Pharmaceuticals International, Inc. (VRX), Mylan, Inc. (MYL) and Pluristem Therapeutics, Inc. (PSTI), each carrying a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment